🇺🇸 FDA
Patent

US 7105169

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use

granted A61KA61K38/164A61K47/6817

Quick answer

US patent 7105169 (Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K38/164, A61K47/6817, A61K47/6833, A61P